top
Please input keywords
OK
Database
News events
Contact us
EN
CN
JP
KR
About us
Introduction
History
Management team
Culture
Social Responsibility
Join us
Antibody Assets
Project Integrum
Antibody discovery platforms
Pipeline
Clinical pipeline
Preclinical pipeline
RenMice
RenMab
RenLite
RenNano
Animal Models
Pharmacology Service
Gene Editing
Collaborations
IR
Stock Information
Financial Reports
Listing Documents
Announcements & Notices
Corporate Governance
Investor Calendar
Email Alert
IR Contact
Home
News events
Downloads
Poster Downloads
Media Center
News
Events
Webinar
Publication
Downloads
Poster Downloads
Brochure
2024
AACR 2024: BCG033, a novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, demonstrates preclinical efficacy against triple-negative breast cancer and other solid tumor xenografts
2024
AACR 2024: TIL analysis demonstrates different mechanisms underlying PD-1 resistance in animal models
2024
AACR 2024: Generation of a novel severely immunodeficient Sprague Dawley rat model for xenograft studies
2024
AACR 2024: A novel humanized NKP46 mouse model to support xenograft studies evaluating NK cell-based cancer immunotherapies
2024
AACR 2024: A novel humanized CD16A model to evaluate efficacy of human antibody therapeutics in triggering ADCC
2024
AACR 2024: Development and validation of humanized HLA mouse model platforms for preclinical evaluation of novel peptide vaccines
2024
AACR 2024: Establishment of a humanized IL5/IL5RA mouse model to evaluate modulators of eosinophilic inflammation in vivo
2024
AACR 2024: Development of humanized VEGFA models to assess preclinical efficacy of novel therapeutics in vivo
2024
AACR 2024: Validation of humanized TL1A mice for advancing preclinical research
1
2
3
4
5
…
14
GO